Evotec's second Capital Markets Day in 2023 was held on 15 November as an on-site event at the Company's headquarters, Manfred Eigen Campus in
The Capital Markets Day featured the following presentations
Welcome Message
Dr
Shaping new Markets: from disease understanding to pipeline building
Dr
PanOmics: from patients for patients
Dr
E.MPD: pipeline building starts with better disease understanding Dr Olivier Radresa, SVP, Head of Nephrology
EVOgnostics: better pipeline building needs better patient stratification
Dr
iPSC: Better pipeline building needs advanced disease modelling
Dr
Efficient pipeline building accelerating with A.I.
Prof. Dr
Integrated platform for iPSC-based Therapeutics
Dr
Dr
Dr
Evotec's next Capital Markets Day will take place on
FORWARD-LOOKING STATEMENTS
This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec's securities. Words such as 'anticipate,' 'believe,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'should,' 'target,' 'would' and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec's expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec.
Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contact:
Hinnerk Rohwedder
Tel: +49 151 40704843
Fax: +49 40 560 81 222
Email: hinnerk.rohwedder@evotec.com
(C) 2023 Electronic News Publishing, source